Intravenous vitamin C in cancer care was pioneered by two-time Nobel Prize recipient and renown scientist Linus Pauling in the 1960s. Since then, many studies have provided compelling scientific and clinical evidence that supports its use in all stages and most types of cancer.
High-dose IVC selectively kills cancer cells while supporting the function of healthy cells, reduces metastases, enhances immune function and lessens the side effects of chemotherapy and radiation therapy.
The process of receiving high-dose IVC is a relatively comfortable experience. Typically, 1-2 infusions are administered per week lasting 1-3 hours each depending upon need.